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The chemical properties of peptide drugs, known as the ‘peptide-drug space’ is considered a 
multi-dimensional subset of the global peptide space. Each dimension represents a chemical 
descriptor which is a numeric variable obtained by in silico calculations or by experiments, 
hiding fundamental physicochemical properties which can be correlated, to varying degrees, with 
biofunctional medicinal properties. Knowledge of this space can increase the efficiency of the 
peptide-drug discovery and development process. 
Using more than 250 peptide drugs already on the market as well as in clinical development and 
starting with more than 3000 physicochemical descriptors for each peptide as well as the specific 
peptide-drug target and clinical use, multivariate data-exploration (e.g. PCA and HCA) was 
performed. Our retrospective analysis indicate that clusters in the peptide-drug space are located 
in a relatively narrow range of the physiochemical space: dense and empty regions were found 
and can be used as guidelines in peptide drug discovery. 
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